Updated Jul 16, 2026
Marquet Magda has filed 6 SEC Form 4 filings across 3 companies in the last 90 days — selling. Lifetime open-market sales: $531K.

Magda Marquet is identified as an insider of AnaptysBio, Inc. (ANAB) in SEC Form 4 filings with CIK 0001631486, most recently on 2026-01-08. The filing records zero purchases and zero sales, and lists one filing in the period; no specific corporate role is disclosed in the filing. AnaptysBio is a clinical-stage biotechnology company focused on antibody therapeutics for inflammation and immuno-oncology.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-17 | TRAX | First Tracks Biotherapeutics, Inc. | M — Option exercise | 6.0K | $0.00 | |
| 2026-05-29 | IMMX | Immix Biopharma, Inc. | A — Grant or award | 6.2K | $0.00 | |
| 2026-01-16 | ANAB | ANAPTYSBIO, INC | S — Open-market sale | 1.7K | $48.85 | $84K |
| 2026-01-16 | ANAB | ANAPTYSBIO, INC | S — Open-market sale | 9.3K | $48.12 | $447K |
| 2026-01-16 | ANAB | ANAPTYSBIO, INC | M — Option exercise | 11.0K | $26.11 | $287K |
Magda Marquet is identified as an insider of AnaptysBio, Inc. (ANAB) in SEC Form 4 filings with CIK 0001631486, most recently on 2026-01-08. The filing records zero purchases and zero sales, and lists one filing in the period; no specific corporate role is disclosed in the filing. AnaptysBio is a clinical-stage biotechnology company focused on antibody therapeutics for inflamma…
6 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($531K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Marquet Magda profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.